Clinical trial / 2012
Curcumin reduced specific inflammatory markers in veterans with sulfur mustard-induced skin complications.
In a randomized, double-blind trial, 96 male veterans with chronic sulfur mustard-induced pruritic skin lesions received 1 g/day curcumin or placebo for four weeks. Curcumin led to significantly greater reductions in serum interleukin-8 and high-sensitivity C-reactive protein (P < 0.001) and decreased calcitonin gene-related peptide (P < 0.001), while interleukin-6 did not change significantly. Changes in interleukin-8 predicted quality of life scores.
- Study type
- Randomized controlled trial
- Who was studied
- 96 male veterans with chronic sulfur mustard skin lesions, Iran
- What was measured
- Serum inflammatory biomarkers, pruritus score, and Dermatology Life Quality Index
THE PAPER
A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications.
Panahi Y, Sahebkar A, Parvin S, Saadat A. Ann Clin Biochem, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.